Daniel Cherñavvsky

Daniel Cherñavvsky

DexCom, Inc. - San Diego / United States
Others
AD Scientific Index ID: 4995325
person_outline Daniel Cherñavvsky's MOST POPULAR ARTICLES
1-) Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese … J Rosenstock, A Jelaska, G Frappin, A Salsali, G Kim, HJ Woerle, ... Diabetes care 37 (7), 1815-1823, 2014 4422014
2-) A randomized trial of closed-loop control in children with type 1 diabetesMD Breton, LG Kanapka, RW Beck, L Ekhlaspour, GP Forlenza, E Cengiz, ...New England Journal of Medicine 383 (9), 836-845, 20202982020
3-) Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosingJ Rosenstock, J Reusch, M Bush, F Yang, M Stewart, ...Diabetes care 32 (10), 1880-1886, 20092942009
4-) Uncompensated polyuria in a mouse model of Bartter\\\'s syndromeN Takahashi, DR Chernavvsky, RA Gomez, P Igarashi, HJ Gitelman, ...Proceedings of the National Academy of Sciences 97 (10), 5434-5439, 20002812000
5-) Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreasBP Kovatchev, E Renard, C Cobelli, HC Zisser, P Keith-Hynes, ...Diabetes care 37 (7), 1789-1796, 20142202014